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ABSTRACT
Objective To determine if a structured complex
intervention increases opportunistic chlamydia screening
testing of patients aged 15–24 years attending English
general practitioner (GP) practices.
Methods A prospective, Cluster Randomised Controlled
Trial with a modiﬁed Zelen design involving 160 practices
in South West England in 2010. The intervention was
based on the Theory of Planned Behaviour (TPB). It
comprised of practice-based education with up to two
additional contacts to increase the importance of screening
to GP staff and their conﬁdence to offer tests through skill
development (including videos). Practical resources
(targets, posters, invitation cards, computer reminders,
newsletters including feedback) aimed to actively inﬂuence
social cognitions of staff, increasing their testing intention.
Results Data from 76 intervention and 81 control
practices were analysed. In intervention practices,
chlamydia screening test rates were 2.43/100 15–24-year-
olds registered preintervention, 4.34 during intervention
and 3.46 postintervention; controls testing rates were 2.61/
100 registered patients prior intervention, 3.0 during
intervention and 2.82 postintervention. During the
intervention period, testing in intervention practices was
1.76 times as great (CI 1.24 to 2.48) as controls; this
persisted for 9 months postintervention (1.57 times as
great, CI 1.27 to 2.30).
Chlamydia infections detected increased in intervention
practices from 2.1/1000 registered 15–24-year-olds prior
intervention to 2.5 during the intervention compared with
2.0 and 2.3/1000 in controls (Estimated Rate Ratio
intervention versus controls 1.4 (CI 1.01 to 1.93).
Conclusions This complex intervention doubled
chlamydia screening tests in fully engaged practices. The
modiﬁed Zelen design gave realistic measures of practice
full engagement (63%) and efﬁcacy of this educational
intervention in general practice; it should be used more
often.
Trial registration The trial was registered on the UK
Clinical Research Network Study Portfolio database.
UKCRN number 9722.
INTRODUCTION
Chlamydia trachomatis is one of the most common
sexually transmitted infections in Europe,1 and sys-
tematic chlamydia testing is offered in at least eight
EU countries in varied healthcare settings.1 In
England, the National Chlamydia Screening
Programme (NCSP) aims to identify and treat
asymptomatic cases through opportunistic screen-
ing of 15–24-year-olds.1 General practices provide
the ﬁrst point of contact for the majority of health-
care in the community in England. They are a
natural setting for detecting infections as over 60%
of young people attend annually;2 the majority of
contraception is prescribed in general practice,3 and
in England, young people have stated a preference
for being tested in their local general practitioner
(GP) practice.4 Only 16% of NCSP tests come
from general practices5 due to many different per-
ceived barriers reported by staff including lack of
time, knowledge, conﬁdence discussing chlamydia
or simply forgetfulness.6
Multifaceted interventions7 with clear targets
and audit,8 9 and based on a cognitive theory10
such as the Theory of Planned Behaviour
(TPB),11 12 are successful at changing behaviour.
The aim of this study was to determine the effect-
iveness of a structured complex intervention13
based on the cognitive TPB11 to increase opportun-
istic chlamydia screening tests of patients aged
15–24 years registered in English general practice.
METHODS
We used a prospective, cluster randomised con-
trolled trial with a modiﬁed Zelen design.14–16
Random allocation is very difﬁcult to conceal in
evaluations of educational interventions, as inter-
vention and control consenting clinicians will know
they are part of a trial and may modify their behav-
iour. Practices may tend to participate in educa-
tional initiatives of particular interest to them;
moreover, research practices may be atypical.
Modiﬁed Zelen design overcomes this potential
bias by not informing any participants that they are
participating in a trial.
Sample sizes
(see Web only ﬁgure 1) To be able to detect at least a
10% absolute increase in screening test rates from
3% to 13%, and allowing for the estimated design
effect, we needed to randomise 80 practices to inter-
vention and 80 to control (see Web only annex 1).
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Setting
We selected general practices registered with the NCSP between
2009 and 2011 from 11 Primary Care Trusts (PCTs) in the
South West of England; this includes a population of 848 000,
15–24-year-olds.
Intervention
The complex intervention13 combining an outreach educational
workshop7 with posters, invitation cards, targets and feedback
of practice testing performance8 and ongoing support, was
based on the TPB11 that proposes our intentions (in this case,
intention to offer a chlamydia screening test) are derived from
the combination of three key factors: personal attitude (whether
a person is aware of beneﬁts of testing),17 subjective norms
(how much a person feels social pressure to test) and perceived
behavioural control (whether the person feels able to offer a
chlamydia test or if there are barriers beyond their own control)
(ﬁgure 2) (see box 1).18 Between April and September 2010, all
intervention practices were offered a practice workshop based
on the TPB13 for all staff (box 1). The Health Protection
Agency researcher (called chlamydia support worker to prevent
unblinding of the study) gave a presentation that aimed to
change personal attitudes to chlamydia testing, covering the epi-
demiology and beneﬁts of diagnosing infections. The practices’
own data were used to develop realistic monthly test targets8 9
based on 15–24 year old practice attendance. Lack of conﬁdence
to offer screens was addressed through videos and through pro-
viding staff with a screening test ‘script’.13 To inﬂuence personal
attitudes and subjective norms, practices were offered posters
stating ‘WE are a chlamydia screening practice’ and patient invi-
tation cards to raise awareness of testing in staff and patients,
sent monthly newsletters including individual practice testing
rates, and to inﬂuence behavioural controls, encouraged to use
computer reminders. The support worker helped staff adapt the
intervention to ﬁt each practice, and identiﬁed a chlamydia
champion to maintain the proﬁle of chlamydia. During the next
9 months practices were offered two contacts to offer further
support, feedback on testing rates and help implement materials.
The practice staff could accept or refuse any part of the
intervention.13
NCSP support during study period
At registration with the NCSP, practices received a screening
information pack and area-speciﬁc training. Over the study
period, control and intervention practices continued to receive
usual support from their local NCSP chlamydia coordinator
who had an overall target chlamydia screening testing rate for
16–24-year-olds in all NCSP venues across their area in 2009 of
25% and 2010 of 35%; coordinators did not know practice
study allocation. Usual support involved a single telephone
contact or visit, availability to answer any queries by telephone,
provision of testing kits when they were needed and partner
notiﬁcation.
Data analysis
Aggregate data by month, age and gender for each registered
GP practice on all chlamydia screening tests in the study area
submitted on a NCSP form for the 3 years (2009–2011) (inclu-
sive) were used to assess the absolute and relative change in
testing/100 and infection detection rates/1000 registered 15–
24-year-old patients, between the intervention, control and non-
study practices during the 1 year period of the intervention, and
in the 9 months after the intervention was formally withdrawn
(see Web only annex 2).
Mixed effects Poisson regression models were used to provide
estimates for both an ‘intention to treat’ analysis in which all
randomised practices were included and a per-protocol analysis
in which intervention practices were matched with the geo-
graphically closest practice of similar size. Numbers of screening
tests or chlamydia infections detected were the outcome vari-
ables and the natural logarithm of the estimated numbers of 15–
24-year-old patients registered at each practice included as an
Figure 2 The Theory of Planned Behaviour and clinician’s intention to undertake chlamydia screening tests.
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Box 1 Intervention components addressing personal attitudes, subjective norms and behavioural controls
1) Changing personal attitudes:
Outcome beliefs, increasing belief in beneﬁts of chlamydia screening tests:
▸ Practice workshop demonstrating how common chlamydia is in 16–24-year-olds, and the beneﬁts of testing a usually asymptomatic
pool of infections to reduce sequelae and onward transmission.
▸ Feedback through newsletters to all staff and to practice ‘champion’, of testing activity and positivity may inﬂuence attitude towards
the value of testing by demonstrating successful testing over time. For example, when increases in uptake and positives are observed,
practice staff may feel that it is worth offering a chlamydia test.
Rewards of action; increasing rewards they will receive by testing:
▸ Develop testing targets based on a practice’s 15–24-year-old population and consultations. Targets can act as a driver, so at the
workshops explore the possibility of agreeing practice targets and milestones as a way of continually monitoring progress and
keeping motivation high.
▸ Feedback testing progress through monthly newsletters and at second practice visit/contact by chlamydia support worker.
▸ Certiﬁcate of training attendance at practice workshop.
▸ Certiﬁcate of personal development after doing on-line quiz.
2) Subjective norms
Normative beliefs (whether they think others believe they should be testing):
▸ Invite all staff to a practice workshop (in protected learning time) to discuss how to offer a chlamydia test in all consultations,
including best practice with under 16-year-olds. This should inﬂuence normative beliefs by affecting whether practice staff think
offering testing is acceptable to patients, and whether they think others in the practice will value them making testing offers.
▸ Practice posters indicating that ‘WE are a chlamydia screening practice’ to show that testing is routine in the practice making it more
acceptable to both staff and patients.
▸ Facilitate practice teamwork through inclusion of chlamydia testing as a standing agenda item at practice meetings. This may
inﬂuence beliefs about whether others in the practice value the fact that ‘I am offering a chlamydia test to all my eligible patients’.
▸ Personal regular newsletters to all the practice staff giving information about chlamydia testing and their latest testing ﬁgures. Make
these ﬁgures available on the website, including anonymous ﬁgures for other practices, so they can see that their peers in other
practices are testing too.
▸ Identify a ‘champion’ for chlamydia testing who acts as a positive role model inﬂuencing whether practitioners believe that others
value them offering chlamydia tests.
▸ Add a pop up for the testing age group (15–24) to normalise the offer.
Motivation to comply; their willingness to test
▸ At practice workshop give evidence that young people who attend general practices in UK or who have collected a testing pack do
want to be tested in general practice.
▸ Demonstrate how quickly and simply an offer of a test can be made, so the time to do so is not perceived as a barrier.
▸ At practice workshop provide evidence that patients can take the sample and complete the form without difﬁculty.
▸ At practice workshop give information about payment levels for testing where a Local Enhanced Service payment is in place.
3) Perceived behavioural control beliefs
Self-efﬁcacy; conﬁdence in ability to test
▸ Practice workshop in protected learning time will improve staff knowledge and self-conﬁdence to offer a test.
▸ Demonstrate how to offer a test via ﬁlm clips delivered as part of practice workshop and also available on the website will inﬂuence
self-efﬁcacy by demonstrating how easy it is to offer a test and give them a ‘script’ to use. The clips covered receptionists handing
out small invitation cards to patients, and GPs offering testing to female and male patients, giving suitable ‘scripts,’ for example,
‘you may have seen the posters in the waiting room indicating WE are a chlamydia screening practice’.
▸ Give practices discreet credit card sized testing invitations for receptionists or other practice staff to give to patients. This makes it
easier for the receptionists to be involved; ﬁlm clip demonstrating the offer will increase conﬁdence in their ability to do so.
▸ Add chlamydia test to templates for consultations with individuals 15–24 years of age, including contraception, asthma, travel and
new patient checks. This will provide staff with ways to approach chlamydia testing thereby increasing conﬁdence, particularly with
male patients.
▸ Web-based education based on the same presentation will allow those who cannot make the practice workshop to undertake the
training and receive a certiﬁcate.
▸ At practice workshop provide staff with a script to use so they know how to offer a test ‘WE are a chlamydia testing practice and you
are in the testing age group—could you do a test today?’
External factors/control beliefs; barriers or facilitators to testing at a practice level
▸ Templates help remind practice staff to discuss chlamydia testing with the target age group.
▸ At practice workshop, present evidence that patients in the age group are happy to be offered a test; thereby overcoming a perceived
behavioural control.
▸ Remove the barrier about asking whether the patient is sexually active and instead offer a test to all patients based on their age.
▸ List the tasks of the identiﬁed ‘champion,’ thus reducing barriers to the champion to increasing testing in the practice by increasing
testing services such as availability of sex-related clinics, leaﬂets, etc that may promote test uptake.
▸ Develop computer prompts to remind clinicians and/or receptionists to give out leaﬂets and/or packs to 15–24-year-old patients. If
this approach is adopted, the chlamydia support worker will work with the practice to develop the computer prompts.
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offset to normalise for variation in list size. The intervention
was included as a categorical variable. In all regression models,
GP practice is considered as a random effect, and sex, age, PCT,
the practice areas deprivation score quintile, quarter within the
year and preintervention chlamydia testing rate were considered
as ﬁxed effects.
RESULTS
No practices withdrew from the NCSP; two controls and one
intervention practice were excluded, as two study practices
merged and one had prior knowledge of the study. Thus we
analysed data from 76 of 77 intervention and 81 of 83 controls.
Forty-seven practices (62%) agreed to three contacts with the
chlamydia support worker, 16 (21%) agreed to one or two con-
tacts and 13 practices (17%) refused all contacts. Staff attend-
ance at the ﬁrst presentation varied; in some all grades of staff
attended a team meeting, in others only GPs or nurses attended.
A total of 76 intervention and 76 control practices have been
used in the per-protocol analysis.
As expected, prior to the intervention there were no import-
ant differences in deprivation, testing rates or chlamydia infec-
tions detected in control, intervention or non-study practices
(table 1).
Intention to treat (table 2): Absolute testing rates across all
practices offered the intervention increased from 2.43 to 4.34/
100 15–24-year-old patients registered with the practices
during the intervention period compared with controls that
increased from 2.61 to 3.00/100 patients; unadjusted rate ratio
1.66 (CI 1.1 to 2.5). The absolute increase in the screening
rates (intervention compared with baseline period) in the inter-
vention practices ranged from −9.6% to 28.8%, the lower,
middle (median) and upper quartile being −0.2%, 2.0% and
3.3%, respectively. For the control practices, these are much
lower than seen in the intervention practices, with the mean
being zero; the range was −6.4% to 7.6%, the lower, middle
(median) and upper quartile being 0.7%, 0% and 1.3%,
respectively. Those intervention practices in the upper quartile
of increased testing were signiﬁcantly more likely to have used
invitation cards, posters and prompts. After allowing for any
imbalance in age, sex, PCT, month, deprivation quintile and
prestudy chlamydia testing rates between each study arm, the
chlamydia testing rate/100 15–24-year-olds in the intervention
practices was 1.76 times as great (CI 1.24 to 2.48, p<0.001)
as control practices in the intervention period. This relative dif-
ference persisted during the 9-month postintervention period
(estimated rate ratio compared with controls 1.57 (95% CI
1.07 to 2.30, p=0.02; absolute testing rate intervention 3.46,
controls 2.82/100 registered patients 15–24 years). There was
no signiﬁcant difference in the intervention effect between men
and women.
Per-protocol results (see Web only table S3) In the 47 practices
that were fully engaged with the intervention, the testing rate
increased by 2.33 times that seen in the control practices (RR
2.33, 95% CI 1.63 to 3.34, p<0.001; absolute rates interven-
tion 5.55, controls 2.85, non-engaged 2.22/100 patients
15–24 years) and this remained 1.97 times as great in the post-
intervention period (RR 1.97, 95% CI 1.40 to 2.77 absolute
rates fully engaged 4.20, non-engaged 1.32, controls 2.45/100
patients 15–24 years). In those 34 practices that used templates/
computer reminders, the testing rate was 2.81 times as great as
in control practices (RR 2.81, 95% CI 1.91 to 4.13, p<0.001,
absolute rate if used prompts 6.52, did not use prompts 1.40/
100 patients 15–24 years) and this remained two times as great
in the postintervention period (RR 2.00, 95% CI 1.36 to 2.94;
absolute rate if used prompts 4.11, did not use prompts 3.04/
100 patients 15–24 years).
Table 1 Baseline data table for GP practices (April 2009–March 2010)
CIRT practices*
intervention
CIRT control
practices
CIRT non-randomised
practices
Number of GP practices 77 83 308
GP practice size
Under 5516 35% 33% 32%
5516–9377 36% 32% 32%
Over 9377 29% 35% 36%
Number of patients 15–24 years in GP practices
Under 625 34% 36% 30%
625–1100 38% 27% 34%
Over 1100 28% 37% 36%
Distribution of practices by deprivation score quintile
1 (highest) 3 (4%) 3 (4%) 5 (2%)
2 14 (19%) 17 (21%) 62 (22%)
3 27 (36%) 27 (33%) 93 (33%)
4 28 (38%) 30 (37%) 118 (41%)
5 (lowest) 2 (3%) 4 (5%) 8 (3%)
% male GPs 52% 51% Not measured
% training practices 42% 54% Not measured
% of all GP Chlamydia tests over the 3 years of data collection (number of tests) 14% (6613) 14% (6580) 46% (21 305)
Screening test rates in year preintervention/100 registered 15–24-year-old patients
(IRR, CI)
2.43 (1.01, 0.66 to 1.56) 2.61 (Reference) 2.29 (0.86, 0.61 to 1.21)
Positive screens in year preintervention/1000 registered 15–24-year-old patients
(IRR, CI)
2.08 (1.03, 0.66 to 1.61) 2.03 (Reference) 1.70 (0.88, 0.62 to 1.25)
*% of practices total allocated to intervention from each PCT: BANES 5%, Bristol 16%. Cornwall 12%, Devon 15%, Gloucestershire 9%, North Somerset 5%, Plymouth 11%, Somerset
12%, South Gloucestershire 5%, Swindon 5%, Wiltshire 5%. CIRT, Chlamydia Intervention Randomised controlled Trial; GP, general practitioner; IRR, incidence rates ratio; PCT, Primary
Care Trust.
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Number of chlamydia infections detected
The absolute numbers of Chlamydia infections detected in inter-
vention practices increased from 2.1 prior to 2.5/1000 regis-
tered 15–24-year-olds during the intervention, compared with
2.0 and 2.3 in control practices; After allowing for the month
of the ﬁrst visit to the practice, and potential confounders
including age, sex, PCT, month, deprivation quintile and base-
line positive screen rates in each practice, the estimated rate
ratio in the intervention practices was 1.4 (95% CI 1.01 to
1.93) times as great in the intervention practices compared with
control practices (p=0.04). Positives detected remained for the
9 months after the intervention (absolute rates intervention 2.5,
controls 1.68/1000 registered 15–24-year-olds; RR 1.6 (95% CI
1.09 to 2.3, p=0.02)).
In fully engaged intervention practices, the number of chla-
mydia infections detected was 1.8 times as great as controls
during the intervention period (95% CI 1.2 to 2.5, p=0.005
absolute rates fully engaged intervention 3.2, controls 2.2,
non-engaged intervention 1.0/1000 patients 15–24 years) and 1.6
times as great in the 9 months after (95% CI 1.1 to 2.4, p=0.03;
absolute rates fully engaged intervention 2.7, controls 1.7,
non-engaged intervention 1.7/1000 patients 15–24 years) than
that seen in the control practices (see supplementary table S3).
DISCUSSION
Main results
This complex intervention within the English chlamydia screen-
ing programme lead to a 76% increase in chlamydia screening
test rates across all practices offered the intervention, with a
40% increase in infections detected. The absolute increase in
testing across all intervention practices was small increasing
from 2.43 to 4.34/100 15–24-year-old patients registered.
However, these results include those practices that did not
accept any visits (17%) from the chlamydia support worker or
did not use all components of the intervention offered. The
62% of practices that agreed to three contacts with the support
worker attained a 2.33 times relative increase in chlamydia
testing.
Strengths
The greatest strength of our study was the modiﬁed Zelen
design, which allowed us to deliver a ‘real life’ evaluation, in
which all practices were invited to participate rather than
research active practices or those enthusiastic about sexual
health. The 62% uptake of three contacts and overall results are
likely to be similar if the intervention was used in other areas
with similar primary care resources. The modiﬁed Zelen design
is particularly useful for the pragmatic evaluation of educational
interventions 16 as participants can accept or decline compo-
nents of the intervention as they would in routine practice
because participants are unaware they are in a trial and so do
not modify their behaviour on that account. The design was
feasible as the primary outcome was measured using routinely
generated NCSP data and consent for practices to take part was
given on their behalf by PCT public and locally respected sexual
health leads. After data collection was complete, all practices
received a letter about the design and consent; no practices
expressed any concerns.
A further strength was TPB-driven intervention design
whereby components (see Web only annex 3) addressed per-
sonal attitudes, subjective norms and perceived behavioural con-
trols. Further, our results demonstrate the importance of
engaging general practices in all parts of such an intervention, as
those practices that only partially engaged or did not use
posters, invitation cards or computer prompts, had non-
signiﬁcant increases in testing. Those practices that agreed to
three contacts with the support worker, demonstrating a positive
personal attitude and practice attitude (subjective norm) to chla-
mydia testing, had a greater increase in screening. These three
contacts also allowed the support worker to discuss testing rates
against targets set at the initial workshop; targets inﬂuence both
personal attitudes and subjective norms. Posters and invitation
cards had a signiﬁcant effect on testing rates and addressed all
components of the TPB, normalising screening within the prac-
tice and increasing awareness, and acted as prompts for testing
invitations for patients, which was demonstrated in the work-
shop videos. Behavioural controls, including lack of time and
forgetfulness, were addressed with the computer prompts used
by 45%.
Limitations
Because of the modiﬁed Zelen design we could not make
practices use all the components of the TPB; however, our per-
protocol analysis allowed us to explore the importance of
Table 2 Absolute numbers of chlamydia tests, testing rates and estimated testing rate ratio obtained from the mixed-effects Poisson regression
model during and 9 months following the intervention period by study group
CIRT intervention practices
CIRT control
practices CIRT non-randomised practices
Number of practices 76 81 286
Number of patients 66 954 79 360 287 964
Study period During 9 m post During 9 m post During 9 m post
Chlamydia screening tests through NCSP
Number in patients 15–24 years 2 907 1 739 2379 1679 7614 5.653
Rate of tests/100 patients 15–24 years 4.34 3.46 3.00 2.82 2.66 2.63
Estimated testing rate ratio mixed effects Poisson regression (CI)
from intention to treat
1.76 (1.24 to 2.48) 1.57 (1.07 to 2.30) Reference Reference 0.93 (0.71 to 1.23) 0.94 (0.69–1.27)
Positive tests (chlamydia infections diagnosed) through NCSP screening tests
Number in patients 15–24 years 164 108 182 118 548 382
Rate/1000 patients 15–24 years 2.5 2.5 2.3 2.3 1.9 2.0
Estimated infections (CI) detected rate ratio mixed-effects
Poisson regression from per-protocol analysis
1.3 (0.9–1.9)
1.4 (1.0–1.9)
1.4 (0.9–2.3)
1.6 (1.1–2.3)
Reference Reference Not in per protocol
analysis
Not in per protocol
analysis
CIRT, Chlamydia Intervention Randomised controlled Trial; NCSP, National Chlamydia Screening Programme.
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individual components. Computer reminders were used by 45%
of the intervention practices, and therefore, the intention-to-
treat analysis for this component is probably valid; however, as
all of the 62% fully engaged practices also used posters and
testing invitation cards, it is not possible to determine the inde-
pendent effect of these latter components. GP practices were
not asked to deliver chlamydia results or undertake contact
tracing. Although NCSP coordinators knew about the study,
they were asked not to discuss it and did not know which prac-
tices were randomised but awareness may have motivated them
to increase their practice support.
How our work ﬁts in
A systematic review has shown that a multifaceted workshop
approach addressing barriers to screening is more effective than
single-component interventions.19 Several studies have demon-
strated that the long-term support is pivotal to increase testing
by maintaining the importance of chlamydia testing (addressing
personal attitudes) and for it to become normal practice (a sub-
jective norm). This approach was successfully used both in an
American adolescent clinic20 in which clinicians participated in
a four-stage clinical improvement initiative with monthly visits
and in two London PCTs where workshops were given with
long-term support.21 In contrast, a single outreach interactive
workshop with several practices together16 led to a lower
increase in testing rates.16 Changing the subjective norms at the
practice and area level are both important. Our initiative
involved single practices across a wide area, and so, they had
little inﬂuence from peers outside their practice, but the London
intervention involved all practices in just two PCTs and gave
testing feedback; 21 this localisation of the intervention may
have had greater inﬂuence on subjective norms and motivated
practices to increase tests.21 The London intervention continued
support for 3 years (compared with only 1 year in our study)
allowing a longer period for testing behaviour change.
Another reason for the greater absolute increase in testing
rates in the London study may have been the ﬁnancial incentives
offered.21 Systematic reviews show that ﬁnancial incentives for
providing a prespeciﬁed level of healthcare activity are generally
effective.22 Financial incentives used to encourage chlamydia
testing will strongly inﬂuence personal attitude and practice sub-
jective norms, but have been shown to be ineffective in isola-
tion23 or to have a short-term effect24 as they are unlikely to
inﬂuence long-term attitudes about the importance of testing
unless combined with other interventions, as in Kalwij’s initia-
tive.21 We also saw a temporary increase in testing prior to April
2009, 2010 and 2011 (see Web only ﬁgure 3), as practices
sought to reach local targets.
Our intervention included a website containing all the presen-
tations, materials and testing rates already provided in direct
practice feedback. However, few GP staff in our study reported
using it, indicating this was not a key part of the intervention.
The need for direct contact with practices is reinforced by the
lack of effectiveness of an internet-based intervention based on
cognitive theory.25
GP staff considered that giving them the skills and conﬁdence
to offer chlamydia tests (overcoming one of the perceived
behavioural controls) was an important part of the intervention;
this was attained through video clips showing clinicians how to
offer chlamydia testing in different consultations. This approach
cannot be used in isolation as shown in a Belgian GP study, in
which a package using commented video footage on communi-
cation skills increased appropriate testing but had no effect on
overall testing rates.26
A Cochrane review found that computer reminders achieved a
median improvement in targeted behaviour of 4.2%,27 but as
the range of change was wide, they suggested further research
to identify other factors consistently associated with larger
improvements.27 Integration of computer alerts to remind
Australian clinicians to screen increased chlamydia testing by
30%.28 Practices that incorporated computer prompts within
our intervention had the greatest increase in testing rates and
this was maintained beyond the end of the intervention. We
consider this is a very cost-effective way of increasing testing but
should not be used in isolation as GP staff may ignore alerts
unless education also increases their belief in testing.
Implications of this research nationally
and for commissioners
Our study and the London service evaluation demonstrate that a
workshop approach with materials and long-term support will
work and is feasible. Although the absolute increase in testing
was small, it is important, as other interventions across the
NCSP have generally not been able to produce a sustained
increase in GP screening and an associated rise in positive tests.
We recommend the NCSP and primary care commissioners con-
sider using this intervention more widely in England and other
countries with similar primary care services. Our analysis indi-
cates that use of all parts of the intervention that inﬂuence dif-
ferent parts of the TPB components and ongoing support are
important to attain the greatest increase in chlamydia screening
tests. Our modiﬁed Zelen design should be considered more
often in educational and public health research as it gives a
much more realistic indication of take-up of the education and
outcomes.
Key messages
▸ A 76% increase in chlamydia screening tests and a 40%
increase in infections detected can be attained across an
area where GP surgeries are offered a multifaceted
educational intervention.
▸ Sixty-two per cent of randomly selected practices in the area
fully engaged with the intervention, and only 17% refused
any contacts; suggesting roll out more widely is feasible.
▸ GP practices that fully engaged with the intervention,
accepting an initial workshop and two further contacts with
the support worker performed 2.33 times more screening
tests during the intervention period compared with control
practices.
▸ The modiﬁed Zelen trial design gives unbiased information
about uptake and success of interventions in randomly
selected GP practices where routine outcome data are
available, and as it is acceptable to practices, should be
used more widely for evaluation.
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